Pengcheng Du
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
- Vibrio bacteria research studies
Papers in
-
- Vibrio bacteria research studies 17
- Escherichia coli research studies 13
-
- Antibiotic Resistance in Bacteria 34
- Co-authors
- Li BaiBiao KanHonghu SunYuping WanHan ZhengJianguo XuChao LiuMarcelo Gottschalk
- Journals
- PLoS ONE (7 papers)Microbiology Spectrum (5 papers)Journal of Clinical Microbiology (5 papers)BMC Microbiology (5 papers)Emerging Microbes & Infections (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Pengcheng Du
146 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 158
- Molecular Medicine 623
- Endocrinology 570
- Microbiology 60
- Infectious Diseases 764
- Microbiology 181
Countries citing papers authored by Pengcheng Du
This map shows the geographic impact of Pengcheng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Du more than expected).
Fields of papers citing papers by Pengcheng Du
This network shows the impact of papers produced by Pengcheng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Du. The network helps show where Pengcheng Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Pengcheng Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 6 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 10 | |
| 10 | 2024 | 0 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 115 | |
| 16 | 2018 | 24 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 45 | |
| 19 | 2015 | 7 | |
| 20 | 2012 | 10 |
About Pengcheng Du
Pengcheng Du is a scholar working on Endocrinology, Molecular Medicine, Microbiology, Infectious Diseases and Clinical Biochemistry, having authored 152 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (34 papers), Salmonella and Campylobacter epidemiology (20 papers), Vibrio bacteria research studies (17 papers), Bacteriophages and microbial interactions (14 papers), Antimicrobial Resistance in Staphylococcus (14 papers), Escherichia coli research studies (13 papers), Bacterial biofilms and quorum sensing (12 papers) and Streptococcal Infections and Treatments (11 papers). The work is most often cited by research in Molecular Medicine (623 citations), Endocrinology (570 citations), Microbiology (60 citations), Infectious Diseases (764 citations) and Microbiology (181 citations). Pengcheng Du has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Li Bai, Biao Kan, Honghu Sun, Yuping Wan, Han Zheng, Jianguo Xu, Chao Liu, Marcelo Gottschalk, Yu Chen and Duochun Wang. Their work appears in journals such as PLoS ONE, Microbiology Spectrum, Journal of Clinical Microbiology, BMC Microbiology and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.